22.49
前日終値:
$21.70
開ける:
$22.5
24時間の取引高:
6.01M
Relative Volume:
1.11
時価総額:
$11.17B
収益:
$4.45B
当期純損益:
$205.00M
株価収益率:
56.22
EPS:
0.4
ネットキャッシュフロー:
$372.00M
1週間 パフォーマンス:
+10.08%
1か月 パフォーマンス:
+6.64%
6か月 パフォーマンス:
+60.76%
1年 パフォーマンス:
+85.26%
Elanco Animal Health Inc Stock (ELAN) Company Profile
名前
Elanco Animal Health Inc
セクター
電話
877-352-6261
住所
450 ELANCO CIRCLE, INDIANAPOLIS
ELAN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
ELAN
Elanco Animal Health Inc
|
22.49 | 10.78B | 4.45B | 205.00M | 372.00M | 0.40 |
|
ZTS
Zoetis Inc
|
123.23 | 53.32B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.53 | 46.16B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.85 | 43.77B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.10 | 34.57B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
500.00 | 21.54B | 3.08B | 1.24B | 1.07B | 25.61 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-09 | 開始されました | Barclays | Overweight |
| 2025-11-21 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2025-11-19 | アップグレード | Argus | Hold → Buy |
| 2025-10-07 | アップグレード | JP Morgan | Neutral → Overweight |
| 2025-07-17 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2025-06-26 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2024-12-09 | 開始されました | UBS | Buy |
| 2024-12-02 | 開始されました | Leerink Partners | Market Perform |
| 2024-09-19 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | アップグレード | Stifel | Hold → Buy |
| 2023-12-19 | 開始されました | Jefferies | Buy |
| 2023-12-15 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | 開始されました | Exane BNP Paribas | Outperform |
| 2023-04-20 | アップグレード | Barclays | Equal Weight → Overweight |
| 2022-08-18 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2022-07-21 | ダウングレード | Goldman | Buy → Sell |
| 2022-07-12 | 開始されました | Piper Sandler | Neutral |
| 2021-11-18 | 開始されました | Morgan Stanley | Overweight |
| 2021-10-28 | ダウングレード | Stifel | Buy → Hold |
| 2021-08-05 | 再開されました | Credit Suisse | Outperform |
| 2021-06-15 | アップグレード | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | アップグレード | Barclays | Underweight → Equal Weight |
| 2021-05-11 | アップグレード | Gabelli & Co | Hold → Buy |
| 2021-04-15 | 開始されました | Stifel | Buy |
| 2021-03-22 | ダウングレード | Gabelli & Co | Buy → Hold |
| 2021-02-26 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | ダウングレード | Argus | Buy → Hold |
| 2020-11-09 | ダウングレード | Barclays | Overweight → Underweight |
| 2020-08-20 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | 再開されました | Credit Suisse | Neutral |
| 2020-08-04 | 再開されました | Goldman | Buy |
| 2020-07-27 | ダウングレード | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | 開始されました | Raymond James | Mkt Perform |
| 2019-12-19 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | 開始されました | Barclays | Overweight |
| 2019-08-26 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | アップグレード | UBS | Sell → Neutral |
| 2019-05-23 | 開始されました | Guggenheim | Neutral |
| 2019-03-18 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | 再開されました | Morgan Stanley | Equal-Weight |
| 2019-02-12 | 開始されました | William Blair | Mkt Perform |
| 2019-01-23 | 開始されました | UBS | Sell |
| 2019-01-15 | 開始されました | Argus | Buy |
| 2018-10-15 | 開始されました | Morgan Stanley | Equal-Weight |
すべてを表示
Elanco Animal Health Inc (ELAN) 最新ニュース
Elanco (ELAN): Valuation Check After Insider Buying Spree and New Restructuring Plan - Yahoo Finance
Elanco Animal Health Director Purchases 10,000 Shares - TradingView — Track All Markets
[Form 4] Elanco Animal Health Inc Insider Trading Activity - Stock Titan
Elanco Animal Health Inc (ELAN) EVP reports 66.4453 deferred stock units - Stock Titan
Elanco Animal Health Inc. (ELAN) CEO reports new deferred stock units award - Stock Titan
Elanco (ELAN) Stock Is Up, What You Need To Know - Finviz
Elanco Animal Health (NYSE:ELAN) Shares Little Changed After Results - Kalkine Media
Elanco Animal Health (NYSE:ELAN) Shares Gap Up Following Insider Buying Activity - MarketBeat
Smart Money Move: Jeffrey N Simmons Grabs $478K Worth Of Elanco Animal Health Stock - Benzinga
Robert M VanHimbergen Takes a Bullish Stance: Acquires $150K In Elanco Animal Health Stock - Benzinga
Are Medical Stocks Lagging Elanco Animal Health (ELAN) This Year? - Yahoo Finance
VIRBAC: Feline Hyperthyroidism: Virbac acquires Thyronorm - GlobeNewswire Inc.
Elanco to Layoff 300 Employees, Shift Another 300 to Other Locations - Hoosier Ag Today
Insider Purchases Boost Elanco (ELAN) Stock - GuruFocus
Elanco Animal Health EVP Modi buys $95,984 in stock By Investing.com - Investing.com South Africa
Elanco Animal Health EVP Modi buys $95,984 in stock - Investing.com
Insider Buying: Elanco Animal Health (NYSE:ELAN) CFO Purchases 6,950 Shares of Stock - MarketBeat
ELAN FinancialsIncome Statement - Quiver Quantitative
Elanco Animal Health EVP VanHimbergen buys $150k in stock - Investing.com
VP Modi Buys 4,500 ($96K) Of Elanco Animal Health Inc [ELAN] - TradingView — Track All Markets
Elanco (ELAN) EVP Rajeev Modi reports purchase of 4,500 shares - Stock Titan
Elanco Animal Health Inc (ELAN) CFO discloses purchase of 6,950 shares - Stock Titan
Elanco Animal Health (ELAN) CEO Jeffrey Simmons adds 22,000 shares - Stock Titan
The career advice Elanco's CEO shares with his six kids - Business Insider
All You Need to Know About Elanco Animal Health (ELAN) Rating Upgrade to Buy - Yahoo Finance
Analysts’ Top Healthcare Picks: Elanco Animal Health (ELAN), Mediwound (MDWD) - The Globe and Mail
Elanco Animal Health Incorporated $ELAN Holdings Cut by Frontier Capital Management Co. LLC - MarketBeat
Stifel Nicolaus Sticks to Their Buy Rating for Elanco Animal Health (ELAN) - The Globe and Mail
Animal Health Focused Elanco Details Pipeline Momentum, US Investments, Cost-Saving Plans - Benzinga
Elanco Animal Health Shifts Focus to U.S., Redefining Livestock R&D and Manufacturing - Bovine Veterinarian
Elanco Animal Health: Strategic Dual Channel Focus and Robust Innovation Pipeline Drive Buy Rating - TipRanks
Elanco Animal Health stock price target raised to $26 at Leerink Partners - Investing.com Canada
Elanco restructuring to affect 600 positions across the company - Feed Strategy
Stifel reiterates Buy rating on Elanco Animal Health stock, maintains $27 price target - Investing.com Canada
Elanco Animal Health (NYSE:ELAN) Rating Increased to Strong-Buy at Barclays - MarketBeat
First Trust Advisors LP Has $35.71 Million Stock Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
American Century Companies Inc. Increases Stock Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Investor Day Defines New Era as Sustainable Growth Company - Finviz
Elanco Invests $400 Million in Indiana to Expand U.S. R&D and Manufacturing Operations - Southeast AgNET
How Protein And Pets Drove Elanco Animal Health's Double-Digit Gain In 2025 - Investor's Business Daily
Elanco Animal Health (NYSE:ELAN) Trading Down 4.5%Should You Sell? - MarketBeat
Elanco (ELAN) Announces Major Cost-Cutting Initiative - GuruFocus
Barclays Initiates Coverage on Elanco Animal Health (ELAN) with Overweight Rating | ELAN Stock News - GuruFocus
Elanco Animal Health Incorporated Announces Organizational Changes - marketscreener.com
Elanco Animal Health (NYSE:ELAN) Coverage Initiated by Analysts at Barclays - MarketBeat
Elanco Animal Health Incorporated Announces Continued Investment in Its U.S. Operations, Workforce and Communities over the Next Five Years - marketscreener.com
Elanco Animal Health Incorporated to Seek M&A - marketscreener.com
Elanco (ELAN) Aims for Major Cost Savings with Strategic Overhau - GuruFocus
Elanco outlines growth plan, restructuring in investor day update By Investing.com - Investing.com
Elanco (ELAN) launches $175M restructuring plan and reaffirms 2025 guidance - Stock Titan
Elanco (NYSE: ELAN) details 3-year outlook with $1.1B 2026 innovation and $1B FCF - Stock Titan
Elanco Animal Health Inc (ELAN) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):